Literature DB >> 16131656

Expression and characterization of soluble amino-terminal domain of NR2B subunit of N-methyl-D-aspartate receptor.

Esther Wong1, Fui-Mee Ng, Chye-Yun Yu, Peiqi Lim, Leng-Hiong Lim, Stephen F Traynelis, Chian-Ming Low.   

Abstract

N-methyl-D-aspartate (NMDA) receptors are involved in mediating excitatory synaptic transmissions in the brain and have been implicated in numerous neurologic disorders. The proximal amino-terminal domains (ATDs) of NMDA receptors constitute many modulatory binding sites that may serve as potential drug targets. There are few biochemical and structural data on the ATDs of NMDA receptors, as it is difficult to produce the functional proteins. Here an optimized method was established to reconstitute the insoluble recombinant ATD of NMDA receptor NR2B subunit (ATD2B) through productive refolding of 6xHis-ATD2B protein from inclusion bodies. Circular dichroism and dynamic light scattering characterizations revealed that the solubilized and refolded 6xHis-ATD2B adopted well-defined secondary structures and monodispersity. More significantly, the soluble 6xHis-ATD2B specifically bound ifenprodil to saturation. Ifenprodil bound to 6xHis-ATD2B with a dissociation constant (KD) of 127.5+/-45 nM, which was within the range of the IC50 determined electrophysiologically. This is the first report on a functional recombinant ATD2B with a characterized KD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131656      PMCID: PMC2253471          DOI: 10.1110/ps.051509905

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  25 in total

1.  Identification of molecular determinants that are important in the assembly of N-methyl-D-aspartate receptors.

Authors:  E Meddows; B Le Bourdelles; S Grimwood; K Wafford; S Sandhu; P Whiting; R A McIlhinney
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

2.  Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A.

Authors:  F Zheng; K Erreger; C M Low; T Banke; C J Lee; P J Conn; S F Traynelis
Journal:  Nat Neurosci       Date:  2001-09       Impact factor: 24.884

3.  Molecular determinants of coordinated proton and zinc inhibition of N-methyl-D-aspartate NR1/NR2A receptors.

Authors:  C M Low; F Zheng; P Lyuboslavsky; S F Traynelis
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  Assembly with the NR1 subunit is required for surface expression of NR3A-containing NMDA receptors.

Authors:  I Perez-Otano; C T Schulteis; A Contractor; S A Lipton; J S Trimmer; N J Sucher; S F Heinemann
Journal:  J Neurosci       Date:  2001-02-15       Impact factor: 6.167

5.  Molecular organization of a zinc binding n-terminal modulatory domain in a NMDA receptor subunit.

Authors:  P Paoletti; F Perin-Dureau; A Fayyazuddin; A Le Goff; I Callebaut; J Neyton
Journal:  Neuron       Date:  2000-12       Impact factor: 17.173

6.  Binding of [3H]ifenprodil, a novel NMDA antagonist, to a polyamine-sensitive site in the rat cerebral cortex.

Authors:  H Schoemaker; J Allen; S Z Langer
Journal:  Eur J Pharmacol       Date:  1990-02-06       Impact factor: 4.432

Review 7.  Protein secondary structure and circular dichroism: a practical guide.

Authors:  W C Johnson
Journal:  Proteins       Date:  1990

Review 8.  Glutamate receptors and transporters in genetic and acquired models of epilepsy.

Authors:  B S Meldrum; M T Akbar; A G Chapman
Journal:  Epilepsy Res       Date:  1999-09       Impact factor: 3.045

9.  Mapping the binding site of the neuroprotectant ifenprodil on NMDA receptors.

Authors:  Florent Perin-Dureau; Julie Rachline; Jacques Neyton; Pierre Paoletti
Journal:  J Neurosci       Date:  2002-07-15       Impact factor: 6.167

10.  Mechanisms of activation, inhibition and specificity: crystal structures of the NMDA receptor NR1 ligand-binding core.

Authors:  Hiroyasu Furukawa; Eric Gouaux
Journal:  EMBO J       Date:  2003-06-16       Impact factor: 11.598

View more
  12 in total

Review 1.  Control of assembly and function of glutamate receptors by the amino-terminal domain.

Authors:  Kasper B Hansen; Hiro Furukawa; Stephen F Traynelis
Journal:  Mol Pharmacol       Date:  2010-07-21       Impact factor: 4.436

2.  Enantiomeric propanolamines as selective N-methyl-D-aspartate 2B receptor antagonists.

Authors:  Yesim A Tahirovic; Matthew Geballe; Ewa Gruszecka-Kowalik; Scott J Myers; Polina Lyuboslavsky; Phuong Le; Adam French; Hasan Irier; Woo-Baeg Choi; Keith Easterling; Hongjie Yuan; Lawrence J Wilson; Robert Kotloski; James O McNamara; Raymond Dingledine; Dennis C Liotta; Stephen F Traynelis; James P Snyder
Journal:  J Med Chem       Date:  2008-09-25       Impact factor: 7.446

3.  Structure of the zinc-bound amino-terminal domain of the NMDA receptor NR2B subunit.

Authors:  Erkan Karakas; Noriko Simorowski; Hiro Furukawa
Journal:  EMBO J       Date:  2009-12-16       Impact factor: 11.598

Review 4.  Allosteric modulators of NR2B-containing NMDA receptors: molecular mechanisms and therapeutic potential.

Authors:  Laetitia Mony; James N C Kew; Martin J Gunthorpe; Pierre Paoletti
Journal:  Br J Pharmacol       Date:  2009-07-08       Impact factor: 8.739

5.  Mapping the high-affinity binding domain of 5-substituted benzimidazoles to the proximal N-terminus of the GluN2B subunit of the NMDA receptor.

Authors:  X-K Wee; K-S Ng; H-W Leung; Y-P Cheong; K-H Kong; F-M Ng; W Soh; Y Lam; C-M Low
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

6.  Synthesis, structural activity-relationships, and biological evaluation of novel amide-based allosteric binding site antagonists in NR1A/NR2B N-methyl-D-aspartate receptors.

Authors:  Cara A Mosley; Scott J Myers; Ernest E Murray; Rose Santangelo; Yesim A Tahirovic; Natalie Kurtkaya; Praseeda Mullasseril; Hongjie Yuan; Polina Lyuboslavsky; Phuong Le; Lawrence J Wilson; Manuel Yepes; Ray Dingledine; Stephen F Traynelis; Dennis C Liotta
Journal:  Bioorg Med Chem       Date:  2009-07-05       Impact factor: 3.641

7.  Binding of spermine and ifenprodil to a purified, soluble regulatory domain of the N-methyl-D-aspartate receptor.

Authors:  Xia Han; Hideyuki Tomitori; Satomi Mizuno; Kyohei Higashi; Christine Füll; Tomohide Fukiwake; Yusuke Terui; Pathama Leewanich; Kazuhiro Nishimura; Toshihiko Toida; Keith Williams; Keiko Kashiwagi; Kazuei Igarashi
Journal:  J Neurochem       Date:  2008-11-05       Impact factor: 5.372

8.  Control of NMDA receptor function by the NR2 subunit amino-terminal domain.

Authors:  Hongjie Yuan; Kasper B Hansen; Katie M Vance; Kevin K Ogden; Stephen F Traynelis
Journal:  J Neurosci       Date:  2009-09-30       Impact factor: 6.167

9.  Zinc inhibition of rat NR1/NR2A N-methyl-D-aspartate receptors.

Authors:  Kevin Erreger; Stephen F Traynelis
Journal:  J Physiol       Date:  2007-11-29       Impact factor: 5.182

10.  The serine protease plasmin cleaves the amino-terminal domain of the NR2A subunit to relieve zinc inhibition of the N-methyl-D-aspartate receptors.

Authors:  Hongjie Yuan; Katie M Vance; Candice E Junge; Matthew T Geballe; James P Snyder; John R Hepler; Manuel Yepes; Chian-Ming Low; Stephen F Traynelis
Journal:  J Biol Chem       Date:  2009-02-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.